HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Eugene Koay, MD,PHD) · ekoay@mdanderson.org · 713-563-2381
Contact: Principal Investigator (Eugene Koay, MD,PHD)

Study leads

Eugene Koay, MD,PHD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Bile Duct Cancer · Cholangiocarcinoma · Cholangiocarcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hangzhou, China

Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China